These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6587821)

  • 1. Ex vivo and in vivo evaluation of drugs that inhibit platelet function.
    Hanson SR; Harker LA
    Ann N Y Acad Sci; 1983; 416():642-50. PubMed ID: 6587821
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
    Arfors KE; Bergqvist D; Tangen O
    Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
    Lorenz R; Siess W; Weber PC
    Eur J Pharmacol; 1981 Apr; 70(4):511-8. PubMed ID: 7238575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of inhibitors of platelet release and aggregation.
    Rosenberg JC; Sell TL
    Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine.
    Chevolet C; Grosdent JC; Reiters GM; Dresse A
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):310-1. PubMed ID: 6817725
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of ticlopidine on platelet function in normal volunteers and in patients with platelet hyperaggregability in vitro.
    Knudsen JB; Gormsen J
    Thromb Res; 1979; 16(5-6):663-71. PubMed ID: 524316
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
    Hanson SR; Harker LA; Bjornsson TD
    J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine diphosphate (ADP)-induced alpha-granules release from platelets of native whole blood is reduced by ticlopidine but not by aspirin or dipyridamole.
    Pengo V; Boschello M; Marzari A; Baca M; Schivazappa L; Dalla Volta S
    Thromb Haemost; 1986 Oct; 56(2):147-50. PubMed ID: 3810554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function.
    Picard-Fraire C
    Thromb Res Suppl; 1983; 4():119-28. PubMed ID: 6356462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of antiplatelet drugs in coronary heart disease.
    Mehta J; Mehta P
    JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
    [No Abstract]   [Full Text] [Related]  

  • 13. Ticlopidine activity on platelet function in patients with enhanced platelet aggregation. A short-term crossover study.
    Gensini GF; Favilla S; Breschi C; Abbate R; Costanzo G; Neri Serneri GG
    Haemostasis; 1983; 13(5):294-300. PubMed ID: 6228500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.
    Buchanan M; Hirsh J
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198423
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet release and aggregation induced by antithymocyte globulin. In vitro effect of inhibitors.
    Rosenberg JC; Sell T
    Transplantation; 1975 Oct; 20(4):346-50. PubMed ID: 169611
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
    de Gaetano G; Bertelé V
    Agents Actions; 1984 Jan; 14(1):109-12. PubMed ID: 6702507
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F
    Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
    [No Abstract]   [Full Text] [Related]  

  • 19. Compared effects of three dose-levels of ticlopidine on platelet function in normal subjects.
    David JL; Monfort F; Herion F; Raskinet R
    Thromb Res; 1979 Jan; 14(1):35-49. PubMed ID: 425084
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiplatelet drugs (author's transl)].
    Dechavanne M; Follea G; Trzeciak MC
    Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.